Triple
T21206809
| Position | Surface form | Disambiguated ID | Type / Status |
|---|---|---|---|
| Subject | John Stuelpnagel |
E522606
|
entity |
| Predicate | boardMemberOf |
P10
|
FINISHED |
| Object | 10x Genomics |
—
|
NE NERFINISHED |
How this triple was built (3 steps)
Every LLM step that produced this triple, in pipeline order — named-entity classification, the disambiguation choices (the exact options shown, with the pick highlighted), and the generated description. The batch + timestamp of each is in the Provenance table below.
NER
Named-entity recognition
gpt-5-mini
Instruction
Given a phrase, classify it is english named entity (e.g., persons, organizations, works of art) in Latin script, or not (e.g., literals, dates, URLs, verbose phrases). For disambiguation, the statement where the phrase occurs as object is also given. Please return a JSON object with `phrase` (string, the phrase being analyzed) and `is_ne` (boolean, indicating whether the phrase is a Named Entity).
Input
Phrase: 10x Genomics | Statement: [John Stuelpnagel, boardMemberOf, 10x Genomics]
NED1
Entity disambiguation (via context triple)
gpt-5-mini-2025-08-07
Target entity: 10x Genomics Context triple: [John Stuelpnagel, boardMemberOf, 10x Genomics]
-
A.
Horizon Discovery
Horizon Discovery is a biotechnology company specializing in gene editing and cell-based research tools used for drug discovery and development.
-
B.
Pacific Biosciences
Pacific Biosciences is a biotechnology company specializing in advanced DNA sequencing technologies, particularly long-read sequencing platforms used in genomics research.
-
C.
Illumina
Illumina is a biotechnology company best known for developing and manufacturing advanced DNA sequencing and array-based technologies used in genomics research and clinical applications.
-
D.
Oxford Nanopore Technologies
Oxford Nanopore Technologies is a biotechnology company that develops and commercializes nanopore-based DNA and RNA sequencing devices for real-time, portable genomic analysis.
-
E.
Nebula Genomics
Nebula Genomics is a personal genomics company that offers whole-genome sequencing and analysis with a focus on privacy-preserving, blockchain-based data sharing.
- F. None of above. chosen
- G. Unsure - the case is ambiguous/there is not enough information to decide.
NED2
Entity disambiguation (via description)
gpt-5-mini-2025-08-07
Target entity: 10x Genomics Target entity description: 10x Genomics is a biotechnology company that develops advanced single-cell and spatial genomics technologies for high-resolution analysis of biological systems.
-
A.
Horizon Discovery
Horizon Discovery is a biotechnology company specializing in gene editing and cell-based research tools used for drug discovery and development.
-
B.
Pacific Biosciences
Pacific Biosciences is a biotechnology company specializing in advanced DNA sequencing technologies, particularly long-read sequencing platforms used in genomics research.
-
C.
Illumina
Illumina is a biotechnology company best known for developing and manufacturing advanced DNA sequencing and array-based technologies used in genomics research and clinical applications.
-
D.
Oxford Nanopore Technologies
Oxford Nanopore Technologies is a biotechnology company that develops and commercializes nanopore-based DNA and RNA sequencing devices for real-time, portable genomic analysis.
-
E.
Nebula Genomics
Nebula Genomics is a personal genomics company that offers whole-genome sequencing and analysis with a focus on privacy-preserving, blockchain-based data sharing.
- F. None of above. chosen
Provenance (2 batches)
The batch behind each pipeline step, in order, with when it ran. Timestamps are batch-level — stages were processed in waves, so the object chain (NER → NED1 → NEDg → NED2) reads in order, but predicate / elicitation batches can sit in a different wave.
| Step | Stage | Batch ID | Status | When |
|---|---|---|---|---|
| creating | Elicitation | batch_69e0b5112d8881909510b2dcdc93106d |
completed | April 16, 2026, 10:08 a.m. |
| NER | Named-entity recognition | batch_69e73435322c8190bf4156fbd14edc5c |
completed | April 21, 2026, 8:24 a.m. |
Created at: April 16, 2026, 3:24 p.m.